Skip to content

Comparative effects of a2 Platimum stage 1 infant formula on infant digestion and comfort: a single-blind randomized controlled trial

Comparative effects of a2 Platimum stage 1 infant formula versus conventional stage 1 infant formula containing A1 and A2ß-casein versus breast feeding on infant digestion and comfort: a single-blind randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000034712
Enrollment
Unknown
Registered
2020-07-16
Start date
2021-06-01
Completion date
Unknown
Last updated
2021-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infant nutrition

Interventions

A2 group:Feeding by formula without A1ß-casein
Formula group:feeding with Aptamil formula
Breastfeeding group:Mainly breastfeeding

Sponsors

Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Subjects included in this study must meet all of the following criteria: 1. 0–76 days of age, inclusive (day of birth is considered day 0); 2. Single tire; 3. Gestational age is 37 – 42 weeks (36 weeks and 6 days is 36 weeks); 4. Birth weight 2500 g to 4500 G; 5. Sign the informed consent form for infants to participate in the study; 6. The parents or guardians of the infant agree not to allow the infant to participate in other intervention clinical studies during the study period; 7. Parents or guardians agree to feed infants according to a randomly assigned formula. In addition to the criteria listed above, subjects in a2 group or formula group must meet the following criteria: Parents or guardians agreed that infants should start on the standard formula as soon as they were enrolled and then switch to the randomly assigned formula at baseline (90 to 105 days) In addition to the criteria listed above, subjects in the breastfeeding group must meet the following criteria: Parents or guardians agree to breastfeed infants.

Exclusion criteria

Exclusion criteria: Subjects who met any of the following criteria must be excluded: 1. Infants with congenital malformations and hereditary and / or chronic and / or congenital diseases that may interfere with the study, such as inability to breastfeed or formula fed; 2. Diseases endangering intrauterine growth; 3. Known or increased risk of IgE mediated cow's milk protein allergy (e.g. biological parents and / or siblings diagnosed with allergy, asthma, hay fever, etc.); 4. Infants with acute infection or gastroenteritis.? 5. Participate in other clinical trials 6. The researchers can not determine whether the parents were willing or able to comply with the protocol requirements (including filling in a diary until the infant was 4 months oldto start feeding complementary foods , and whether they were able and willing to collect, process and store faeces as instructed) 7. Immunocompromised infants (based on a doctor's diagnosis of immunodeficiency, such as combined immunodeficiency, DiGeorge syndrome, Wiskott-Aldrich syndrome, severe congenital neutropenia and HIV infection-related secondary immunodeficiency, Down syndrome, etc.) and children with known head/brain diseases/injuries,Such as microcephaly, megacephaly, etc 8. Feeding difficulties or formula intolerance, such as vomiting or insufficient intake, were present at randomization

Design outcomes

Primary

MeasureTime frame
Crying;

Secondary

MeasureTime frame
Fecal SCFA, MPO, CRP, lactic acid and intestinal flora;Salivary inflammatory indicators;

Countries

China

Contacts

Public ContactJiangqin Liu

Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine

jiangqinliu@163.com+86 13482867540

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026